Immunogenicity and Serum Neutralizing Activity of Recombinant Avian Reovirus σC Antigens Produced in Bacterial and Plant Expression Systems

Avian reovirus (ARV) is an important poultry pathogen characterized by substantial genetic variability, which may compromise the effectiveness of vaccines based on classical strains. This study evaluated recombinant σC antigens produced in bacterial and plant-based expression systems as adaptable vaccine candidates against ARV. Seven Chilean field isolates collected over a five-year period were characterized through S1 sequencing and phylogenetic analysis. Most isolates clustered within genotype V, whereas one belonged to genotype I. Isolate 13726, which showed the greatest divergence among genotype V isolates and approximately 49% amino acid identity with the classical S1133 vaccine strain, was selected for recombinant antigen production. The σC protein was successfully expressed in Escherichia coli and transiently in Nicotiana benthamiana using a Tobacco mosaic virus-derived pTRBO vector, yielding recombinant proteins of approximately 35 kDa. Purified antigens were formulated with Montanide ISA 760 VG and administered to specific-pathogen-free chickens using a prime-boost vaccination schedule. Both recombinant formulations induced significant anti-σC antibody responses, which increased following booster immunization. Virus neutralization assays against homologous ARV isolate 13726 showed an approximately two-log reduction in infectivity. The pooled serum from chickens immunized with the N. benthamiana-derived formulation produced a neutralization index (NI) of 2.005, whereas pooled sera from the E. coli-derived formulation and the commercial Reomune® 3 vaccine produced NI values of 1.996 and 2.006, respectively. Because neutralization was assessed using pooled sera, these values were interpreted descriptively and were not subjected to statistical comparison among treatments.

Authors

Institutions

Publication Details

Journal
Veterinary Sciences
Published
2026-11-19
DOI
https://doi.org/10.3390/vetsci13111246
Primary Topic
Animal Virus Infections Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Immunogenicity and Serum Neutralizing Activity of Recombinant Avian Reovirus σC Antigens Produced in Bacterial and Plant Expression Systems

Miguel Guzmán, Lisette Lapierre, Leonardo Sáenz, Sonia Vidal et al.
Veterinary Sciences
Animal Virus Infections Studies
article

Immunogenicity and Serum Neutralizing Activity of Recombinant Avian Reovirus σC Antigens Produced in Bacterial and Plant Expression Systems

Miguel Guzmán, Lisette Lapierre, Leonardo Sáenz, Sonia Vidal, Francisca Cáceres, Alejandra Guerrero‐Moncayo, Larry Grill
article en

Abstract

Avian reovirus (ARV) is an important poultry pathogen characterized by substantial genetic variability, which may compromise the effectiveness of vaccines based on classical strains. This study evaluated recombinant σC antigens produced in bacterial and plant-based expression systems as adaptable vaccine candidates against ARV. Seven Chilean field isolates collected over a five-year period were characterized through S1 sequencing and phylogenetic analysis. Most isolates clustered within genotype V, whereas one belonged to genotype I. Isolate 13726, which showed the greatest divergence among genotype V isolates and approximately 49% amino acid identity with the classical S1133 vaccine strain, was selected for recombinant antigen production. The σC protein was successfully expressed in Escherichia coli and transiently in Nicotiana benthamiana using a Tobacco mosaic virus-derived pTRBO vector, yielding recombinant proteins of approximately 35 kDa. Purified antigens were formulated with Montanide ISA 760 VG and administered to specific-pathogen-free chickens using a prime-boost vaccination schedule. Both recombinant formulations induced significant anti-σC antibody responses, which increased following booster immunization. Virus neutralization assays against homologous ARV isolate 13726 showed an approximately two-log reduction in infectivity. The pooled serum from chickens immunized with the N. benthamiana-derived formulation produced a neutralization index (NI) of 2.005, whereas pooled sera from the E. coli-derived formulation and the commercial Reomune® 3 vaccine produced NI values of 1.996 and 2.006, respectively. Because neutralization was assessed using pooled sera, these values were interpreted descriptively and were not subjected to statistical comparison among treatments.

Veterinary SciencesVol. 13(11)
University of Chile (CL), Keck Graduate Institute (US)
Animal Virus Infections Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon